Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Rang in aandelen #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Aandeelprijs
$4.00
Laatst gesynchroniseerd: 2026-08-20
Marktkapitalisatie
$75.37M
Verandering (1 dag)
0.00%
Verandering (1 jaar)
12.99%
Land
US
Handel RetinalGenix Technologies Inc. (RTGN)

Categorie

Dividendrendementgeschiedenis voor RetinalGenix Technologies Inc. (RTGN)
Het dividendrendement (TTM) van RetinalGenix Technologies Inc. (aandelsymbool: RTGN) per 2026 is: 0
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van RetinalGenix Technologies Inc. (RTGN) van 2026 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten